Skip to search boxSkip to navigationSkip to main content

Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody

*Corresponding author for this work
Research Output:
Contribution to journal
Article
Research
Peer-review

Abstract

<p>Sequential sampling from animals challenged with highly pathogenic organisms, such as haemorrhagic fever viruses, is required for many pharmaceutical studies. Using the guinea pig model of Ebola virus infection, a catheterized system was used which had the benefits of allowing repeated sampling of the same cohort of animals, and also a reduction in the use of sharps at high biological containment. Levels of a PS-targeting antibody (Bavituximab) were measured in Ebola-infected animals and uninfected controls. Data showed that the pharmacokinetics were similar in both groups, therefore Ebola virus infection did not have an observable effect on the half-life of the antibody.</p>

Research Output Information

Output type

Research Output:
Contribution to journal
Article
Research
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 108-111 (4 pages)

Journal (Volume, Issue Number)

Antiviral Research (Volume 97, Issue 2)

Publication milestones

  • Published - 02/2013

Publication status

Published - 02/2013

ISSN

0166-3542

Publication IDs

  • Scopus: 84871894016
  • PubMed: 23165089

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well